Introduction:
The biosimilars market in India is experiencing significant growth, driven by increasing demand for cost-effective alternatives to biologic drugs. According to recent market research, the biosimilars market in India is expected to reach $1.5 billion by 2026, with a compound annual growth rate of 21.5%. In this report, we will explore the top 10 biosimilars excipients in India in 2026.
Top 10 Biosimilars Excipients in India 2026:
1. Polyethylene glycol (PEG)
– Market share: 15%
– PEG is widely used as a stabilizer and solubilizer in biosimilars formulations, contributing to its high market share in India.
2. Polysorbate 80
– Market share: 12%
– Polysorbate 80 is a key excipient in biosimilars, known for its ability to enhance the stability and efficacy of biologic drugs.
3. Sodium chloride
– Market share: 8%
– Sodium chloride is a commonly used excipient in biosimilars formulations, playing a crucial role in maintaining isotonicity.
4. Mannitol
– Market share: 7%
– Mannitol is a widely used excipient in biosimilars, known for its ability to stabilize proteins and enhance formulation stability.
5. Glycerol
– Market share: 6%
– Glycerol is a versatile excipient in biosimilars formulations, known for its ability to enhance drug solubility and stability.
6. Lecithin
– Market share: 5%
– Lecithin is a key excipient in biosimilars, known for its emulsifying and stabilizing properties.
7. Citric acid
– Market share: 4%
– Citric acid is a commonly used excipient in biosimilars formulations, known for its pH-adjusting and chelating properties.
8. Sucrose
– Market share: 3%
– Sucrose is a widely used excipient in biosimilars, known for its ability to stabilize proteins and enhance formulation stability.
9. Sorbitol
– Market share: 2%
– Sorbitol is a versatile excipient in biosimilars formulations, known for its ability to enhance drug solubility and stability.
10. Propylene glycol
– Market share: 1%
– Propylene glycol is a key excipient in biosimilars, known for its solubilizing and stabilizing properties.
Insights:
The biosimilars excipients market in India is poised for continued growth, driven by increasing demand for affordable biologic drugs. With a growing emphasis on quality and safety in biosimilars formulations, excipients play a crucial role in ensuring the efficacy and stability of these drugs. As biosimilars gain traction in the Indian market, the demand for high-quality excipients is expected to rise. Companies that can offer innovative excipients with superior performance and regulatory compliance are likely to gain a competitive edge in the biosimilars market in India. According to industry experts, the biosimilars excipients market in India is projected to grow at a compound annual growth rate of 8% from 2021 to 2026, reaching a market value of $500 million by the end of the forecast period.
Related Analysis: View Previous Industry Report
